The purpose of this study is to evaluate the safety and effectiveness of bright light therapy for patients with melanoma and non-small cell lung cancer (NSCLC).
In this study, bright light therapy will be provided via an iPad at the participant's home for 60 minutes total.
Participation is expected to last 3 weeks.
Detailed eligibility will be reviewed when contacting the study team.